Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report. [electronic resource]
Producer: 20021104Description: 460-9 p. digitalISSN:- 0923-7534
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- adverse effects
- Child, Preschool
- Etoposide -- adverse effects
- Female
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Ifosfamide -- adverse effects
- Infant
- Infusions, Intravenous
- Kidney Neoplasms -- drug therapy
- Male
- Neoplasm Recurrence, Local -- drug therapy
- Remission Induction
- Survival Rate
- Treatment Outcome
- Wilms Tumor -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.